Alkermes plc (ALKS)
Free
No email, no account, no signup.
Pulling latest news for Alkermes plc…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals for CNS and sleep
Market Cap
$5.9B
We're already tracking Alkermes plc — here are the latest events we've registered
Recent News
- On May 5, 2026, Alkermes reported Q1 2026 financial results, highlighting a revenue increase to $392.9 million driven by the acquisition of Avadel Pharmaceuticals and its narcolepsy drug LUMRYZ. The company also updated its 2026 guidance, narrowing its projected GAAP net loss and increasing EBITDA expectations following the integration of the new assets.
Want to know how this news affects Alkermes plc? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Alkermes plc will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.